Fact Sheet for Healthcare Providers: KPMAS COVID-19 Test – Kaiser Permanente Mid-Atlantic States | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: KPMAS COVID-19 Test – Kaiser Permanente Mid-Atlantic States

06/13/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/13/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the KPMAS COVID-19 Test. The KPMAS COVID-19 Test is authorized for use on nasal swab specimens self-collected by individuals at home, using the KPMAS COVID-19 Home Collection Kit, when determined by a healthcare provider to be appropriate. (PDF)